ROCKVILLE, Md., Nov. 7, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF - News) today announced that it will restate certain previously issued financial statements to correct for errors related to stock-based compensation. On November 5, 2007, Cytomedix determined that the financial statements for the fiscal year ended December 31, 2006, and for each of the quarters in 2006 and 2007, should no longer be relied upon because of errors in such financial statements. The Board of Directors has discussed this determination with the Company’s management, outside counsel, its current registered public accounting firm, PricewaterhouseCoopers LLP, and its prior registered public accounting firm, L J Soldinger Associates, LLC.
